- Sprache
-
Englisch
- Identifier
-
1248480198
Thema
Therapeutics; Cancer--Research
Beteiligte Personen und Organisationen
Illes, Bernhard
Engelke, Hanna
Engelke, Hanna
- DOI
-
10.5282/edoc.27244
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Objekttyp
- Monografie
Beteiligte
- Illes, Bernhard
- Engelke, Hanna
Ähnliche Objekte (12)
Directed invasion and migratory modes of cancer cells in structured 3D collagen matrices
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
STED Nanoscopy to Illuminate New Avenues in Cancer Research – From Live Cell Staining and Direct Imaging to Decisive Preclinical Insights for Diagnosis and Therapy
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Investigation of Molecular Mechanisms of Therapy Resistance in Lung Cancer by Mathematical Modeling
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Evaluation of Mesoporous Silica Nanoparticles for Head and Neck Cancer Therapy
DUPA α-Amanitin Conjugates for Targeted Prostate Cancer Therapy - Optimization and Evaluation of In Vivo Potency
Clinical evaluation of CAP7.1 in therapy refractory biliary tract cancer in a randomized phase II trial
α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
Directed invasion and migratory modes of cancer cells in structured 3D collagen matrices
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
STED Nanoscopy to Illuminate New Avenues in Cancer Research – From Live Cell Staining and Direct Imaging to Decisive Preclinical Insights for Diagnosis and Therapy
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Investigation of Molecular Mechanisms of Therapy Resistance in Lung Cancer by Mathematical Modeling
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Evaluation of Mesoporous Silica Nanoparticles for Head and Neck Cancer Therapy
DUPA α-Amanitin Conjugates for Targeted Prostate Cancer Therapy - Optimization and Evaluation of In Vivo Potency
Clinical evaluation of CAP7.1 in therapy refractory biliary tract cancer in a randomized phase II trial
α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
Directed invasion and migratory modes of cancer cells in structured 3D collagen matrices
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
STED Nanoscopy to Illuminate New Avenues in Cancer Research – From Live Cell Staining and Direct Imaging to Decisive Preclinical Insights for Diagnosis and Therapy
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Investigation of Molecular Mechanisms of Therapy Resistance in Lung Cancer by Mathematical Modeling
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Evaluation of Mesoporous Silica Nanoparticles for Head and Neck Cancer Therapy
DUPA α-Amanitin Conjugates for Targeted Prostate Cancer Therapy - Optimization and Evaluation of In Vivo Potency
Clinical evaluation of CAP7.1 in therapy refractory biliary tract cancer in a randomized phase II trial